Asthma Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Asthma is a chronic respiratory condition marked by bouts of shortness of breath and wheezing. Although asthma can strike at any age, it is the most common condition among children. Respiratory infections and environmental variables such as allergens, tobacco, smoke, and indoor and outdoor pollutants have been related to asthma attacks. Mold, chemicals, strong odors, and house dust are examples of indoor pollution, whereas air pollution, allergens, tobacco, and smoking are examples of outdoor pollution. Asthma development and aggravation are caused by such variables.

The global asthma therapeutics market is predicted to develop due to an increase in the number of occurrences of respiratory disease.

The Asthma Therapeutics Market is predicted to develop due to the rising prevalence of respiratory disorders. According to a report published by the World Health Organization (WHO) in 2016, around 235 million individuals worldwide suffer from asthma on a yearly basis. Asthma is a life-threatening respiratory condition that progresses over time. As a result, the worldwide asthma treatments market is expected to grow as the number of cases of respiratory disease rises.

Furthermore, rising awareness activities are assisting in the expansion of the worldwide asthma treatments market. In May 2019, for example, Koninklijke Philips N.V. started a campaign to raise awareness of asthma and other respiratory disorders, particularly in youngsters. 'Help Your Child Fight Asthma' was the slogan for this campaign.

Furthermore, a product recall is a major restraint that is projected to stifle the Asthma Therapeutics Market growth. Camber Pharmaceuticals, for example, got a product recall letter from the US Food and Drug Administration (USFDA) in August 2018 for its Montelukast Sodium Tablets. Because of this, these tablets have been recalled. Losartan Potassium Tablets are contained in Montelukast Tablet bottles branded as Montelukast Sodium Tablets.

The Competitive Landscape of the Global Asthma Therapeutics Market

GlaxoSmithKline Plc., Philips Healthcare, AstraZeneca Plc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Sanofi-Aventis SA, CareFusion Corporation, Sunovion Pharmaceuticals, Inc., Merck & Co., Inc., and Roche Diagnostics are among the major players in the asthma therapeutics market.